115 related articles for article (PubMed ID: 2374140)
21. Effect of the antiandrogen, WIN 49,596, on the descent of the testis in the male rat.
Bluestein D; Lemmi CA; Miller L; Geesaman B; Rajfer J
J Urol; 1991 May; 145(5):1103-5. PubMed ID: 2016802
[TBL] [Abstract][Full Text] [Related]
22. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity.
Muhn P; Fuhrmann U; Fritzemeier KH; Krattenmacher R; Schillinger E
Ann N Y Acad Sci; 1995 Jun; 761():311-35. PubMed ID: 7625729
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the rodent Hershberger bioassay: testing of coded chemicals and supplementary molecular-biological and biochemical investigations.
Freyberger A; Ellinger-Ziegelbauer H; Krötlinger F
Toxicology; 2007 Sep; 239(1-2):77-88. PubMed ID: 17688994
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of steroid-induced prostatic hyperplasia in rats by treatment with anti-androgen (TZP-4238).
Murakoshi M; Tagawa M; Inada R; Suzuki M; Mizokami A; Watanabe K
Endocr J; 1993 Aug; 40(4):479-88. PubMed ID: 7522800
[TBL] [Abstract][Full Text] [Related]
25. Prolactin influence on cytosol and nuclear androgen receptors in the ventral, dorsal, and lateral lobes of the rat prostate.
Prins GS
Endocrinology; 1987 Apr; 120(4):1457-64. PubMed ID: 3493896
[TBL] [Abstract][Full Text] [Related]
26. Effect of combination treatment with zanoterone (WIN 49596), a steroidal androgen receptor antagonist, and finasteride (MK-906), a steroidal 5 alpha-reductase inhibitor, on the prostate and testes of beagle dogs.
Juniewicz PE; Hoekstra SJ; Lemp BM; Barbolt TA; Devin JA; Gauthier E; Frenette G; Dube JY; Tremblay RR
Endocrinology; 1993 Aug; 133(2):904-13. PubMed ID: 8393778
[TBL] [Abstract][Full Text] [Related]
27. Antiandrogen. III. 11-oxapregnane steroids.
Takegawa S; Koizumi N; Mieda M; Shibata K
Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):746-8. PubMed ID: 8681406
[TBL] [Abstract][Full Text] [Related]
28. [The antiandrogenic effect of dimethachlon and its mechanism].
Zhang GJ; Zheng YF; Zhu HJ; Zhu XQ
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2004 Feb; 22(1):15-8. PubMed ID: 15033008
[TBL] [Abstract][Full Text] [Related]
29. Antiandrogenic effects in vitro and in vivo of the fungicide prochloraz.
Vinggaard AM; Nellemann C; Dalgaard M; Jørgensen EB; Andersen HR
Toxicol Sci; 2002 Oct; 69(2):344-53. PubMed ID: 12377983
[TBL] [Abstract][Full Text] [Related]
30. 17 beta-acylurea derivatives of 4-azasteroids as inhibitors of testosterone 5 alpha-reductase.
Di Salle E; Briatico G; Giudici D; Ornati G; Nesi M; Panzeri A
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):765-8. PubMed ID: 1373305
[TBL] [Abstract][Full Text] [Related]
31. Comparison of anti-androgenic activity of flutamide, vinclozolin, procymidone, linuron, and p, p'-DDE in rodent 10-day Hershberger assay.
Kang IH; Kim HS; Shin JH; Kim TS; Moon HJ; Kim IY; Choi KS; Kil KS; Park YI; Dong MS; Han SY
Toxicology; 2004 Jul; 199(2-3):145-59. PubMed ID: 15147789
[TBL] [Abstract][Full Text] [Related]
32. The combined antiandrogenic effects of five commonly used pesticides.
Birkhøj M; Nellemann C; Jarfelt K; Jacobsen H; Andersen HR; Dalgaard M; Vinggaard AM
Toxicol Appl Pharmacol; 2004 Nov; 201(1):10-20. PubMed ID: 15519604
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization of an imidazolopyrazole as novel selective androgen receptor modulator.
Zhang X; Allan GF; Tannenbaum P; Sbriscia T; Linton O; Lai MT; Haynes-Johnson D; Bhattacharjee S; Lundeen SG; Sui Z
J Steroid Biochem Mol Biol; 2013 Mar; 134():51-8. PubMed ID: 23098693
[TBL] [Abstract][Full Text] [Related]
34. [Antiandrogenic effects of cypermethrin and beta-cypermethrin].
Wu W; Zhang J; Zhu W; Zheng YF; Zhu HJ; Xu M; Zhu XQ
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Apr; 26(4):193-7. PubMed ID: 18724888
[TBL] [Abstract][Full Text] [Related]
35. (+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an orally potent and peripherally selective nonsteroidal androgen receptor antagonist.
Kinoyama I; Taniguchi N; Toyoshima A; Nozawa E; Kamikubo T; Imamura M; Matsuhisa A; Samizu K; Kawanimani E; Niimi T; Hamada N; Koutoku H; Furutani T; Kudoh M; Okada M; Ohta M; Tsukamoto S
J Med Chem; 2006 Jan; 49(2):716-26. PubMed ID: 16420057
[TBL] [Abstract][Full Text] [Related]
36. Antiandrogenic activity of epitestosterone in male mice in vivo.
Stárka L; Broulík PD
Sb Lek; 2001; 102(1):7-11. PubMed ID: 11830921
[TBL] [Abstract][Full Text] [Related]
37. Effects of steroidal and non-steroidal antiandrogens on the androgen binding properties of the rat ventral prostate androgen receptor.
Steinsapir J; Mora G; Muldoon TG
Biochim Biophys Acta; 1991 Aug; 1094(1):103-12. PubMed ID: 1883848
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and pharmacological evaluation of new 16-methyl pregnane derivatives.
Ramirez E; Cabeza M; Heuze I; Gutiérrez E; Bratoeff E; Membrillo M; Lira A
Chem Pharm Bull (Tokyo); 2002 Jan; 50(1):15-20. PubMed ID: 11824579
[TBL] [Abstract][Full Text] [Related]
39. Investigation of a mechanism for Leydig cell tumorigenesis by linuron in rats.
Cook JC; Mullin LS; Frame SR; Biegel LB
Toxicol Appl Pharmacol; 1993 Apr; 119(2):195-204. PubMed ID: 8480329
[TBL] [Abstract][Full Text] [Related]
40. Anti-androgen TSAA-291. VII. On the mechanism of anti-androgenic action of 16 beta-ethyl-17 beta-hydroxy-4-oestren-3-one (TSAA-291).
Nakayama R; Masuoka M; Hiraga K; Miki T
Acta Endocrinol Suppl (Copenh); 1979; 229():100-7. PubMed ID: 294104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
